Bill
Bill > H1307
MA H1307
MA H1307Establishing a study to examine the feasibility of state manufactured generic prescription drugs
summary
Introduced
03/29/2021
03/29/2021
In Committee
03/29/2021
03/29/2021
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
Relative to the manufacture of generic prescription drugs by the Commonwealth. Health Care Financing.
AI Summary
This bill requires the Health Policy Commission to conduct a study examining the feasibility of establishing a program for the Commonwealth of Massachusetts to manufacture generic prescription drugs. The study will analyze factors that contribute to increasing drug costs in the state, the impact of generic drug costs on MassHealth spending and overall healthcare costs, and whether a state-run generic drug manufacturing program could effectively reduce drug prices and healthcare costs. The Commission will submit a report with its findings and recommendations, including a cost-benefit analysis, within one year of the bill's passage.
Committee Categories
Health and Social Services
Sponsors (10)
Smitty Pignatelli (D)*,
Brian Ashe (D),
John Barrett (D),
Michelle Ciccolo (D),
Josh Cutler (D),
Jamie Eldridge (D),
Tricia Farley-Bouvier (D),
Tami Gouveia (D),
Elizabeth Malia (D),
Dan Sena (D),
Last Action
Accompanied S771 (on 11/17/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/192/H1307 |
| Bill | https://malegislature.gov/Bills/192/H1307.pdf |
Loading...